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Visualisation to enhance biomechanical tuning of
ankle-foot orthoses (AFOs) in stroke: study
protocol for a randomised controlled trial
Bruce Carse1*, Roy J Bowers2, Barry C Meadows3 and Philip J Rowe1
Abstract
Background: There are a number of gaps in the evidence base for the use of ankle-foot orthoses for stroke
patients. Three dimensional motion analysis offers an ideal method for objectively obtaining biomechanical gait
data from stroke patients, however there are a number of major barriers to its use in routine clinical practice. One
significant problem is the way in which the biomechanical data generated by these systems is presented. Through
the careful design of bespoke biomechanical visualisation software it may be possible to present such data in
novel ways to improve clinical decision making, track progress and increase patient understanding in the context
of ankle-foot orthosis tuning.
Methods: A single-blind randomised controlled trial will be used to compare the use of biomechanical
visualisation software in ankle-foot orthosis tuning against standard care (tuning using observation alone).
Participants (n = 70) will have experienced a recent hemiplegia (1-12 months) and will be identified by their care
team as being suitable candidates for a rigid ankle-foot orthosis. The primary outcome measure will be walking
velocity. Secondary outcome measures include; lower limb joint kinematics (thigh and shank global orientations) &
kinetics (knee and hip flexion/extension moments, ground reaction force FZ2 peak magnitude), step length,
symmetry ratio based on step length, Modified Ashworth Scale, Modified Rivermead Mobility Index and EuroQol
(EQ-5D). Additional qualitative measures will also be taken from participants (patients and clinicians) at the
beginning and end of their participation in the study. The main aim of the study is to determine whether or not
the visualisation of biomechanical data can be used to improve the outcomes of tuning ankle-foot orthoses for
stroke patients.
Discussion: In addition to answering the primary research question the broad range of measures that will be
taken during this study are likely to contribute to a wider understanding of the impact of ankle-foot orthoses on
the lives of stroke patients.
Trial registration number: ISRCTN: ISRCTN52126764
Keywords: Ankle-foot orthosis, biomechanics, gait analysis, visualisation, stroke, hemiplegia, 3D motion analysis
Background
Post-stroke AFO use
There is currently a limited amount of published evi-
dence that a rigid ankle-foot orthosis (AFO) fitting can
improve mobility and indirectly quality of life for stroke
patients [1-3]. While assessment for AFO in stroke
patients is recommended, the grade of recommendation
in recently published Scottish Intercollegiate Guidelines
Network (SIGN) clinical guidelines remains low [4].
This low grading of recommendation reflects the lack of
evidence on the impact of AFO on both functional and
long-term outcomes. It was also noted that there was
insufficient evidence regarding the comparative effects
of different types of AFO. Guidance on screening and
assessment for the provision of AFO for stroke patients
is now available in an NHS Scotland Best Practice State-
ment [5].
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AFO tuning
AFO tuning involves making small dimensional changes
at the foot and ankle that can have a significant positive
biomechanical effect at the knee and hip in children
with cerebral palsy [6-9]. Appendix 7 of the NHS BPS
[5] provides guidance on how to tune an AFO effectively
for stroke patients. Given the supposed important role
of AFO tuning, it is surprising that in previous AFO
stroke studies there are limited descriptions of the
AFOs used in terms of; position of leg during casting or
scanning, materials used, tuning process followed (if
any) and heel wedge sizes.
While the majority of AFO tuning studies have con-
sidered children with cerebral palsy, one describes a
case study with a stroke patient [10]. The authors found
that AFO tuning did have a positive effect on stride
length and a reduction in knee hyperextension.
Gait analysis
Observational gait analysis has been shown to be inef-
fective and unreliable [11,12] while computerised 3D
gait analysis results have been shown to have a signifi-
cant impact on clinical decision making [13,14], thus
strengthening the argument for the use of objective
computerised gait analysis techniques. Despite compu-
terised gait analysis being shown to have a significant
impact on surgical decision making there are a number
of perceived barriers to its use. Baker described many of
these barriers and identified the interpretation of clinical
gait data as being a significant problem [15]. Further-
more, Coutts stated that “interpretation of biomechani-
cal data is complex, time consuming and not readily
understood by most therapists” [16]. Other barriers
include the cost of the motion analysis equipment, the
high level of technical expertise required to operate it
and the time needed to collect patient data. Physiothera-
pists and orthotists in the UK rarely have access to com-
puterised 3D gait laboratories to assist with their clinical
decision making [17].
Physiotherapists and orthotists play pivotal roles in the
multi-disciplinary team (MDT) approach advocated by
the NHS BPS [5] and in the context of AFO tuning
there is a clear need for a method of making biomecha-
nical gait data easier to understand through having a
user-friendly interface and a rapid presentation of key
gait parameters. One study found that there were signif-
icant inter-disciplinary differences in how gait data is
analysed [17], so there is a need for a common gait ana-
lysis language that can be understood by a range of
healthcare professionals.
3D motion analysis and AFO tuning
The results of a pilot study where a rigorous biomecha-
nical approach to AFO fitting and tuning was used, with
ten stroke patients, showed that correct use of AFOs
improved a number of important gait characteristics
[18]. The results showed significant improvements in
ground reaction force (GRF) vector alignment at the hip
and an increase in step length for the affected limb as
well as an overall increase in walking velocity. Other
improvements were also found in GRF alignment at the
knee, step length and knee extension of the unaffected
limb. Given the small sample sizes used in the pilot
study, the more powerful study described here is
justified.
Previous work in the area of visualising biomechanical
data has shown that animation techniques can enhance
both older adult, health professional and design profes-
sionals’ understanding of the biomechanics of everyday
tasks [19]. Given the complex biomechanical nature of
AFO tuning, it follows that this activity could benefit
from the use of 3D motion analysis combined with a
biomechanical visualisation tool (to interpret the data).
This may help the MDT administering the treatment
package and subsequently improve patient outcomes.
This study constitutes one part of a wider project
called envisage. The envisage project will investigate
the use of visualisation software to help communicate
biomechanical data in a variety of rehabilitation settings.
The project represents a multidisciplinary collaboration
between the University of Strathclyde, The Glasgow
School of Art and Glasgow Caledonian University.
Primary research question
Does visualisation of biomechanical data improve the
outcomes of tuning ankle-foot orthoses (AFOs) for
stroke patients?
Secondary research questions
1. Can biomechanical visualisation enhance ortho-
tists’ and physiotherapists’ understanding of
biomechanics?
2. Could a visualisation tool facilitate better commu-
nication between the members of the multidisciplin-
ary team?
3. Does a patient’s understanding of their own bio-
mechanics and corresponding treatment programme
change when a visualisation tool is used?
4. Can a database of anonymous gait data on the
effects of AFO on stroke patients be created?
Methods/design
Study design - Single-blind RCT
The null hypothesis of the study is that there is no dif-
ference in outcome measures for stroke patients
between observation-based AFO tuning and objective
AFO tuning with 3D motion analysis and biomechanical
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visualisation software. The alternative hypothesis is that
objective AFO tuning with biomechanical visualisation
software improves outcome measures for stroke
patients.
A single-blind randomised controlled trial (RCT)
methodology has been selected to test this hypothesis as
shown in Figure 1. The patients will be blinded as to
the intervention they will be given, however the
Figure 1 Flow diagram of trial design showing intervention (visualisation) and non-intervention (observation) arms.
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clinicians involved will not be blinded. The independent
assessor conducting the statistical analysis on the main
trial outcome measures will also be blinded. The main
benefit of using an RCT is that any potential selection
bias and confounding factors will be minimised.
The randomisation sequence will be generated using
an independently verified S-PLUS program, by the
method of randomised permuted blocks of length four,
with participants allocated to interventions in a 1:1
ratio. Researchers will access the random allocations via
the study web portal (designed and maintained by The
Robertson Centre for Biostatistics at The University of
Glasgow) and the sequence will remain concealed until
the participant’s details are registered on the system.
As patients are recruited to the trial they will be ran-
domly allocated to one of two multidisciplinary teams
(MDTs). Each of these MDTs will be made up of a phy-
siotherapist, orthotist and bioengineer. MDT-A will
administer the intervention arm of the study, MDT-B
will administer the non-intervention arm. In the inter-
vention arm patients will be shown visualisations of
their gait patterns and progress throughout the trial.
Additionally, the clinicians in MDT-A will also be able
to use the gait data and visualisation software to aid
their clinical decision making during the AFO tuning
session. MDT-B will conduct AFO tuning using stan-
dard observational techniques.
Baseline, outcome (3 months) and follow-up (6
months) measurement sessions will be collected by the
bioengineer and a third physiotherapist who is indepen-
dent of the MDTs.
All clinical decision making will be carried out by the
physiotherapists and orthotists, while the bioengineer
will play a purely technical role collecting data and pre-
senting it to the clinicians and the patient when it is
required. The same bioengineer will be used in both
MDTs and will be present during all sessions.
Ideally both MDTs would be identical, but this is
clearly not possible. Two different MDTs are needed to
avoid learning effects in the intervention arm of the
study crossing over to the non-intervention and con-
founding results. In order to balance the MDTs, team
members will be selected such that they have similar
levels of experience and they will all be required to
complete a small amount of basic biomechanics
refresher training before the trial commences.
In order to ensure that patients in both arms of the
study receive similar AFOs before the tuning stage, a set
of design criteria were agreed which both orthotists will
follow. These criteria specify the type and thickness of
material to be used, angle of ankle dorsiflexion, the pre-
tuning shank-to-vertical angle of the AFO when com-
bined with footwear, the trim lines, carbon fibre reinfor-
cements to be used and the positioning/functionality of
the straps. See sub-section ‘Rigid AFO Design Criteria’
for more detail.
Measurement sessions
AFO scanning and fitting
When a patient is recruited to the study they will be
randomised and assigned to one arm of the study. The
appropriate orthotist will scan them for a rigid AFO and
deliver the AFO according to the set of design criteria
unique to this study. After scanning and prior to AFO
fitting and tuning, the baseline measures can be taken.
Baseline
All patients will have baseline gait measurements taken
using a 3D motion analysis system. After measurements
have been taken, patients in the intervention arm will
additionally be shown relevant visualisations which will
help to explain and quantify their gait problems.
Tuning
Patients in the intervention arm will be given AFO tun-
ing with visualisation. Patients in the non-intervention
arm will be given AFO tuning using observational tech-
niques. All patients will have gait measures taken at the
end of the tuning process, wearing their tuned AFO.
Outcome measures (3 months)
All patients will have 3 month gait measurements taken
using a 3D motion analysis system. Patients in the inter-
vention arm will have their progress discussed, aided by
visualisations of the data measurements just taken.
Follow-up measures (6 months)
All patients will have 6 month gait measurements taken
using a 3D motion analysis system. Patients in the inter-
vention arm will have their progress discussed, aided by
visualisations of the data measurements just taken.
Participant recruitment (inclusion/exclusion criteria)
The stroke physiotherapy team will identify stroke
patients who are suitable for AFO treatment and will
notify the researcher of those considered to meet all of
the inclusion/exclusion criteria (see Table 1). The
researcher will then inform them of the study and if
they are interested they will be given a copy of the
‘information for participants’ sheet to read. The patient
will be given a suitable amount of time (minimum of 48
hours) to consider volunteering. During this time they
will be free to ask for more information from the
researcher about the study and to consult with friends,
carers or relatives.
Communication problems are common in stroke
patients, so the patient’s care team will be asked to
assess the patient’s capacity for making informed con-
sent. In addition to providing the ‘participant informa-
tion’ sheet the care team will also take the time to
verbally explain the trial to the patient if required. It
will be made clear to the patient that treatment will not
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be withheld if they decline to participate in the trial.
They will still receive an AFO and an AFO tuning ses-
sion if they do not volunteer. If they agree to participate
in the trial they will be asked to sign a ‘research partici-
pant consent form’. Should the patient be unable to sign
or to mark a document so as to indicate his/her con-
sent, it can be given orally in the presence of at least
one witness and recorded in writing. Suitable verbal and
graphical explanations will supplement the consent pro-
cess as necessary on an individual basis. The ‘informa-
tion for participants’ sheet makes it clear that the
patient is free to withdraw from the study at any time,
without giving reason and that withdrawal will not their
standard of care nor their future treatment.
Sample size (power calculation used)
The sample size was decided upon by using data from
previous similar studies. A clinically relevant change in
walking velocity has been identified as 0.2 m/s [20].
Using conservative figures from a previous RCT [21] the
standard deviation of the treatment effect in a control
population was 0.24 m/s. This provided a standardised
difference statistic of 0.831, which suggests that a sam-
ple size of 62 (31 per group) will give 90% power at 5%
significance level. Seventy participants (35 per group)
will allow for a withdrawal rate of > 10%.
Location
Participants will be recruited from the stroke wards at
the Southern General Hospital, Glasgow, UK. Baseline,
tuning, 3 month and 6 month sessions will all take
place at West of Scotland Mobility and Rehabilitation
Centre (WestMARC) at the Southern General Hospital,
Glasgow, UK.
Data collection equipment
3D motion analysis will be carried out using and 8-cam-
era Vicon 612 motion analysis system (Oxford Metrics,
UK) in conjunction with 2 AMTI BP400600 force
platforms.
Quantitative data collected (Primary and Secondary
outcome measures)
The primary outcome measure for this study is walking
velocity [22]. Secondary outcome measures include;
lower limb joint kinematics (thigh and shank global
orientations) & kinetics (knee and hip flexion/extension
moments, ground reaction force FZ2 peak magnitude),
step length, symmetry ratio based on step length [23],
Modified Ashworth Scale [24], Modified Rivermead
Mobility Index [25,26], EuroQol (EQ-5D) [27].
Qualitative data
The quantitative outcome measures of the RCT are not
sufficient to answer all of the study’s secondary research
questions, so through the use of qualitative research
methods it is anticipated that an enhanced understand-
ing of the effects of using visualisations in AFO tuning
can be acquired [28]. This part of the study will explore
what effect the use of the visualisation tool has on the
experiences and understanding of patients and clinicians
involved in the study, as well as what effect it has on
the patient-clinician interactions.
One-to-one semi-structured interviews will be con-
ducted with all clinicians and patients both before and
after their participation in the study.
Before the study, after they have consented to partici-
pate, all patients will be required to complete short (15
minute) interviews. The main focus of the questions will
be on their expectations of the AFO process, their per-
sonal goals and their personal perception of their walk-
ing ability at the baseline stage. Clinicians will also
complete slightly longer (30 minute) interviews which
concentrate on how confident they feel about biomecha-
nics, what they look for during observational gait analy-
sis (are there any inter-disciplinary differences?),
attitudes towards 3D motion analysis and perceived dif-
ficulties in communicating gait abnormalities to health
professionals from other disciplines.
After their participation in the study all patients will
complete 30 minute interviews, covering a range of
Table 1 Participant inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Inpatients who have suffered a recent (1-12 months) hemiplegia Are unable to give informed consent
Aged 16-80 years Are unable to walk, even when assisted
Male or Female Suffer from significant peripheral vascular disease ? not suitable for
fitting of AFO
Have difficulty walking, but able to walk with/without assistance Have any other significant medical problems likely to preclude use of
AFO or follow-up
Have difficulty flexing knee and extending hip during walking
Meet the criteria for AFO referral as outlined in AFO screening tool (NHS
BPS, Appendix 9)
Able to give informed consent
Able to attend for follow-up at 3 and 6 months
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topics including; patient-clinician communication,
understanding of their treatment, motivation levels, per-
sonal goals achieved, impact of visualisations. Their per-
sonal perception of their walking ability will also be
reassessed. Clinicians will also complete 45 minute
interviews, which will investigate themes such as; evi-
dence of enhanced understanding of biomechanics, team
working, perceived benefits/drawbacks of using software
and confidence in their clinical decision making.
Statistical Analysis
Quantitative data from the four patient measurement
sessions (baseline gait, AFO tuning, three and six month
gait) will be analysed on an ‘intention to treat’ basis.
Data will be held independently on a bespoke database
at the Robertson Centre for Biostatistics at the Univer-
sity of Glasgow, and independent assessors comparing
data sets will be blinded as to which arm of the trial
each patient was allocated to.
The primary emphasis of the statistical analysis will be
on between-group differences to establish if differences
in outcome measures are apparent. This will be achieved
using two-way repeated measures ANOVA analysis, fol-
lowed by a series of post-hoc tests which are most likely
to be t-tests.
All data will be tested for normality, and where nor-
mality does not occur the equivalent nonparametric
tests will be used instead. A significance level of 0.05
will be used and a Bonferroni correction will be used
when multiple t-tests are required. Qualitative data
obtained from the various interviews will be collated
and a suitable coding system established such that the
responses can be categorised.
Rigid AFO Design Criteria
Each rigid AFO used in the trial will be made to the fol-
lowing criteria:
1. The AFO must not position the ankle in a more
dorsiflexed position than can be achieved with the
knee fully extended (i.e. the gastrocnemius length).
This means the AFO may hold the ankle in a plantar
flexed position.
2. The AFO should give an initial shank-to-vertical
angle of 0 degrees when placed on a flat surface
without a shoe. A permanent wedge should be
attached to achieve this if the AFO holds the ankle
in a plantar flexed position.
3. 5 mm homopolymer polypropelene should be
used.
4. Carbon fibre reinforcements should be used, with
their leading edge placed at the midline of each
malleolus.
5. There should be no noticeable deflection when
the AFO is forced into plantarflexion or dorsiflexion.
There should be no outward bulging at the malleoli
when the AFO is forced into dorsiflexion.
6. Trimlines should be approximately 1 cm anterior
to the midline of the malleioli. At the forefoot, the
medial and lateral trimlines should be close to the
metatarsal heads, to allow for control of supination/
pronation. The sole plate should extend at least 5
mm beyond the toes.
7. Straps should be made of velco (or webbing
backed with velcro). The top strap should be no
more than 10-15 from the top of the AFO. The
lower strap should apply a force in a posterior and
inferior direction, at roughly 45 degrees to the verti-
cal, to the dorsum of the foot.
Ethical Approval
This study received ethical approval from NHS West
of Scotland Research Ethics Committee 4 on 1st April
2011 (Ref:11/AL/0166). NHS Greater Glasgow and
Clyde R&D approval granted 19th July 2011 (Ref:
GN10OR216).
Discussion
This protocol describes an early exploratory phase ran-
domised controlled trial [29] which aims to assess the
impact of using biomechanics visualisation in the con-
text of AFO tuning with stroke patients.
The visualisation software design team worked closely
with bioengineers, physiotherapists and orthotists to
gain an understanding of the AFO tuning process. This
work involved informal research methods from conver-
sations and observation of current working practices
through to more formal focus group discussions. It is
anticipated that an appropriate biomechanics visualisa-
tion software tool has been developed. The work sug-
gested that only a small, very specific, subset of gait
parameters is necessary for making clinical decisions
and measuring progress for AFO tuning. The visualisa-
tion software tool will take the data collected with con-
ventional 3D motion analysis equipment and display it
in novel visual ways to benefit both clinicians and
patients (see Figure 2). Only the smallest number of gait
parameters necessary will initially be presented to clini-
cians to help them make quick and accurate clinical
decisions based on objective numerical data. It is antici-
pated that this will go some way to addressing the afore-
mentioned problems of interpreting gait analysis [16].
As well as potentially benefitting from any improved
decision making from the clinicians, the patient may
also benefit from having the advantages of their AFO
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explained to them and also having any progress they are
making highlighted at the outcome and follow-up stages.
One particular strength of this study is that the
authors have attempted to address the problem of pre-
vious studies failing to provide sufficient levels of detail
when describing the participants recruited and/or the
orthosis being investigated [30].
As this is a relatively small-scale study, it is limited
slightly by only having two MDTs so there is a chance
that the patient outcomes will be influenced by the skills
knowledge and experience of the individual MDT mem-
bers, and the resulting group dynamics. However, all
MDT members will be practicing NHS professionals
whose primary aim is to provide the best possible care
for the patient, and as mentioned previously they will all
be given some basic biomechanics refresher training
before the trial commences.
While primarily focussed on gait related outcome
measures, this study aims to develop a richer under-
standing of the effects of AFO use in stroke patients.
Through the use of outcome measures such as the EQ-
5D, Modified Rivermead Mobility Index, Modified Ash-
worth scale and various qualitative measures a clearer
picture of what overall impact AFOs have on stroke
patients lives should become apparent.
Trial Status
The trial is ongoing.
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